BioAtla, Inc. (BCAB)
1.26
-0.06
(-4.55%)
USD |
OTCM |
Sep 08, 16:00
BioAtla Price : 1.26 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 1.35 | 1.45 | 1.16 | 1.26 | 39866.00 |
| Sep 04, 2026 | 1.25 | 1.39 | 1.16 | 1.32 | 19068.00 |
| Sep 03, 2026 | 1.17 | 1.30 | 1.15 | 1.30 | 14813.00 |
| Sep 02, 2026 | 1.08 | 1.40 | 1.08 | 1.205 | 20307.00 |
| Sep 01, 2026 | 1.51 | 1.70 | 1.07 | 1.08 | 117479.0 |
| Aug 31, 2026 | 1.76 | 2.13 | 1.31 | 1.69 | 130236.0 |
| Aug 28, 2026 | 1.58 | 2.100 | 1.51 | 1.735 | 1.034M |
| Aug 27, 2026 | 3.15 | 3.245 | 3.07 | 3.14 | 31335.00 |
| Aug 26, 2026 | 3.35 | 3.37 | 3.06 | 3.12 | 21465.00 |
| Aug 25, 2026 | 3.28 | 3.47 | 3.09 | 3.26 | 55312.00 |
| Aug 24, 2026 | 3.27 | 4.00 | 3.10 | 3.28 | 393763.0 |
| Aug 21, 2026 | 3.26 | 3.41 | 3.03 | 3.18 | 88744.00 |
| Aug 20, 2026 | 3.24 | 3.35 | 3.14 | 3.18 | 19035.00 |
| Aug 19, 2026 | 3.28 | 3.325 | 3.04 | 3.27 | 47223.00 |
| Aug 18, 2026 | 3.01 | 3.25 | 2.98 | 3.18 | 30262.00 |
| Aug 17, 2026 | 3.12 | 3.135 | 2.81 | 3.06 | 207130.0 |
| Aug 14, 2026 | 3.43 | 3.50 | 3.00 | 3.09 | 144034.0 |
| Aug 13, 2026 | 3.41 | 3.463 | 3.20 | 3.45 | 156540.0 |
| Aug 12, 2026 | 3.55 | 3.60 | 3.28 | 3.38 | 64065.00 |
| Aug 11, 2026 | 3.56 | 3.56 | 3.37 | 3.50 | 45225.00 |
| Aug 10, 2026 | 3.54 | 3.630 | 3.37 | 3.47 | 69044.00 |
| Aug 07, 2026 | 3.33 | 3.708 | 3.274 | 3.46 | 37090.00 |
| Aug 06, 2026 | 3.35 | 3.535 | 3.274 | 3.33 | 39627.00 |
| Aug 05, 2026 | 3.635 | 3.700 | 3.27 | 3.325 | 44462.00 |
| Aug 04, 2026 | 3.39 | 3.487 | 3.27 | 3.35 | 58437.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 82.66 |
| Oncolytics Biotech, Inc. | 0.7993 |
| Sangamo Therapeutics, Inc. | 0.1609 |
| Sarepta Therapeutics, Inc. | 22.00 |
| Anixa Biosciences, Inc. | 2.84 |
Price Related Metrics
| PS Ratio | 7.237 |
| Earnings Yield | -19.42% |
| Market Cap | 2.096M |